NRC
National Research Corporation
There isn't enough reported data to score NRC yet.
NRC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Weak |
NRC's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is weak.
NRC PE Valuation
NRC has no meaningful PE right now: it lost money over the past year.
NRC Forward outlook
There aren't enough analyst estimates for NRC to show an outlook.
NRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | $0.69 | -39% |
| Q2 2025 | $0.75 | -38% |
| Q1 2025 | $1.02 | -18% |
| Q4 2024 | $1.04 | -17% |
| Q3 2024 | $1.13 | -2.6% |
| Q2 2024 | $1.21 | +3.4% |
| Q1 2024 | $1.24 | +2.5% |
| Q4 2023 | $1.25 | -1.6% |
NRC's earnings per share have fallen from their peak: $0.69 over the past year, against $1.47 in late 2020.
NRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $38.4M | +11% |
| Q2 2026 | $35.4M | +4% |
| Q1 2026 | $34.8M | +3.7% |
| Q4 2025 | $35.2M | -4.6% |
| Q3 2025 | $34.6M | -3.4% |
| Q2 2025 | $34M | -2.8% |
| Q1 2025 | $33.6M | -5% |
| Q4 2024 | $36.9M | -2.9% |
NRC's revenue has held roughly level: $38M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +0.8 points |
| Q2 2026 | -9.2% | -14 points |
| Q1 2026 | 16% | -9.6 points |
| Q4 2025 | 13% | -13 points |
| Q3 2025 | 22% | +0.1 points |
| Q2 2025 | 4.7% | -21 points |
| Q1 2025 | 26% | +0.8 points |
| Q4 2024 | 26% | -4.8 points |
NRC's operating margin was 23% last quarter, up 0.8 points from the same quarter a year ago.
NRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7M | -31% |
| Q2 2026 | $62K | +$4.2M |
| Q1 2026 | $5.3M | +46% |
| Q4 2025 | $6.1M | +213% |
| Q3 2025 | $10.2M | +30% |
| Q2 2025 | -$4.1M | -374% |
| Q1 2025 | $3.7M | -54% |
| Q4 2024 | $1.9M | -76% |
NRC still generates free cash flow, though less than at its 2020 peak: $18M over the past year.
NRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -122K shares |
| 1 year | -1.1% | -243K shares |
| 3 years | -11% | -2.8M shares |
| 5 years | -15% | -3.8M shares |
| Available history | -13% | -3.1M shares |
NRC has 22M diluted shares, down 1.1% from a year ago, with $26M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $16M |
| Q2 2026 | $7.6M |
| Q1 2026 | $1.9M |
| Q4 2025 | $1,000 |
| Q3 2025 | $9.3M |
| Q2 2025 | $6M |
| Q1 2025 | $4.9M |
| Q4 2024 | $7.4M |
NRC spent $26M buying back its own shares over the past year, down 7.3% from the year before.
NRC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 3.7x | Elevated |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.4x | Moderate |
| Q3 2020 | 0.1x | Very low |
| Q2 2020 | 0.4x | Very low |
| Q1 2020 | 0.4x | Very low |
| Q4 2019 | 0.3x | Very low |
NRC's net debt is about 4.1 years of its operating earnings (EBITDA), up from less than a year a year ago.
NRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.6 | Overbought |
| Stochastic | 87.0 | Overbought |
NRC's weekly RSI is 73 (overbought) and its Stochastic is 87 (overbought).
NRC PE vs Healthcare Sector
| Metric | NRC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
NRC has no meaningful PE right now: it lost money over the past year.
NRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.3 | 19% above |
| 20 week MA | $21.7 | 23% above |
| 50 week MA | $19.3 | 38% above |
| 100 week MA | $17.0 | 56% above |
| 200 week MA | $26.4 | 0.9% above |
NRC has climbed back above all five of its weekly moving averages, and it's now 0.9% above its 200-week average.
NRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66.6 | $44.4 | -33% |
| 2021 | $44.4 | $41.5 | -6.5% |
| 2022 | $41.5 | $37.3 | -10% |
| 2023 | $37.3 | $39.6 | +6.1% |
| 2024 | $39.6 | $17.4 | -56% |
| 2025 | $17.4 | $18.7 | +7.1% |
| 2026 YTD | $18.7 | $26.6 | +43% |
NRC is up 43% so far in 2026, after finishing lower in four of the previous six years.